Robert G Finizio's Net Worth

$48.3 Million

Estimate Recalculated Sep 9, 2024 12:37AM EST

Who is Robert G Finizio

Robert G Finizio has an estimated net worth of $48.3 Million. This is based on reported shares across multiple companies, which include TherapeuticsMD, Inc., and ZyVersa Therapeutics, Inc..

SEC CIK

Robert G Finizio's CIK is 0001532235

Past Insider Trading and Trends

2018 was Robert G Finizio's most active year for acquiring shares with 17 total transactions. Robert G Finizio's most active month to acquire stocks was the month of November. 2018 was Robert G Finizio's most active year for disposing of shares, totalling 33 transactions. Robert G Finizio's most active month to dispose stocks was the month of November. 2019 saw Robert G Finizio paying a total of $449,018.80 for 159,406 shares, this is the most they've acquired in one year. In 2014 Robert G Finizio cashed out on 1,082,053 shares for a total of $7,170,822.92, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TherapeuticsMD, Inc.

CEO
Updated Jul 02, 2021
Form 4
2.24M
Jul 02, 2021
2.24M
Grant
Jul 01
Form 4
-0.37%
-67.70K
$1.04
-$70.40K
May 12, 2021
20.31M
Sale
May 10 - May 11
Form 4
-3.66%
-679.96K
$0.85
$0.16
Mar 08, 2021
19.90M
Options
Feb 28 - Mar 05
Form 4
1.00
Nov 27, 2020
1.00
Grant
Nov 24
Form 4
0.25%
46.00K
$1.44
$66.36K
Jun 10, 2020
20.40M
Purchase
Jun 09
Form 4
0.16%
30.00K
$1.15
$34.60K
Jun 08, 2020
20.36M
Purchase
Jun 05
Form 4
950.00K
Apr 01, 2020
950.00K
Grant
Mar 30
Form 4
0.39%
72.00K
$2.75
$198.00K
Oct 29, 2019
20.33M
Purchase
Oct 25
Form 4
1.00
Aug 30, 2019
1.00
Grant
Aug 28
Form 4
0.19%
35.00K
$2.74
$95.90K
Aug 20, 2019
20.25M
Purchase
Aug 20
Form 4
-0.80%
-147.59K
$2.96
$155.12K
Aug 12, 2019
20.22M
Grant
Feb 28 - Aug 09
Form 4
-1.00%
-184.91K
$1.88
-$658.28K
Dec 21, 2018
20.37M
Sale
Scheduled
Dec 19 - Dec 20
Form 4
-1.12%
-211.00K
$2.34
-$825.46K
Dec 10, 2018
20.55M
Sale
Scheduled
Dec 06 - Dec 07
Form 4
-0.97%
-184.00K
$2.47
-$870.36K
Nov 28, 2018
20.76M
Sale
Scheduled
Nov 26 - Nov 27
Form 4
-0.96%
-184.00K
$2.43
-$858.86K
Nov 14, 2018
20.95M
Sale
Scheduled
Nov 12 - Nov 13
Form 4
-0.95%
-184.00K
$2.69
-$953.34K
Oct 29, 2018
21.13M
Sale
Scheduled
Oct 25 - Oct 26
Form 4
-0.94%
-184.00K
$2.83
-$1.00M
Oct 15, 2018
21.31M
Sale
Scheduled
Oct 11 - Oct 12
Form 4
-0.93%
-184.00K
$3.37
-$1.20M
Sep 24, 2018
21.50M
Sale
Scheduled
Sep 20 - Sep 21
Form 4
-0.93%
-184.00K
$3.17
-$1.13M
Sep 10, 2018
21.68M
Sale
Scheduled
Sep 06 - Sep 07
Form 4
440.00K
Mar 19, 2018
440.00K
Grant
Mar 15
Form 4
445.00K
Mar 17, 2017
445.00K
Grant
Mar 15
Form 4
950.00K
Dec 21, 2015
950.00K
Grant
Dec 17
Form 4
0.30%
63.05K
$3.00
$94.58K
May 12, 2014
21.33M
Options
May 09
Form 4
-4.46%
-982.05K
$6.70
-$6.58M
Mar 28, 2014
21.03M
Sale
Mar 26
Form 4
-0.23%
-50.00K
$6.17
-$308.69K
Feb 21, 2014
22.01M
Sale
Scheduled
Feb 19 - Feb 21
Form 4
-0.23%
-50.00K
$5.70
-$285.23K
Jan 23, 2014
22.06M
Sale
Scheduled
Jan 21 - Jan 23
Form 4
23.72%
950.00K
Dec 04, 2012
4.95M
Grant
Apr 16 - Nov 30
Form 4
2.53%
50.00K
Apr 17, 2012
2.03M
Grant
Apr 16
Form 4
17.88%
300.00K
Mar 16, 2012
1.98M
Grant
Feb 27
Form 3/A
Mar 16, 2012
22.16M
Form 3
Oct 11, 2011
22.16M
Showing 31 results

ZyVersa Therapeutics, Inc.

Investor
Updated Jul 18, 2024
Form 4
132.00
Jul 18, 2024
132.00
Grant
May 24
Form 4
59.56K
Dec 14, 2022
59.56K
Grant
Dec 12
Form 3
Dec 13, 2022
Showing 3 results